Crane Co (CR) Stock News

Crédit Agricole Alpes Provence has made available its financial report as of June 30, 2026. The document has been submitted to the Financial Markets Authority and is accessible on the company's website and regulatory information section.

Security Risk Advisors' Chief Marketing Officer Joe Cicero has been recognized as a finalist in CRN's Best of the Channel Awards for Best Channel Visionary of the Year. The recognition highlights his success in unifying marketing, alliances, and sales into a growth engine, building a partner-led Co-Sell model with Microsoft that influenced over $10M in services revenue, and advancing SRA's alliance capabilities including MISA membership and MXDR Verified designation.

Following ARGAN's proposed merger with WDP announced on July 23, 2026, Standard & Poor's has placed ARGAN's 'BBB-' issuer credit rating on Positive CreditWatch, indicating a potential upgrade to 'BBB' upon merger completion in Q1 2027. The combined entity would benefit from increased scale, geographic diversification, reduced tenant concentration risk, and a stronger financial profile.

Following the announcement of its proposed merger with WDP, Standard & Poor's has placed ARGAN's BBB- credit rating on CreditWatch with positive outlook, signaling a potential upgrade of at least one notch. S&P cited the merger's expected benefits including increased size, strengthened rental income profile, expanded geographic diversification, and reduced client concentration risk, positioning the combined entity as a European logistics real estate leader.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (CRMT) for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. The firm is preparing a class action lawsuit to recover investor losses.

Crédit Agricole Nord de France announced robust first-half 2026 financial results with consolidated net income rising 61.3% to €194.4M, driven by strong commercial activity, improved credit margins, and favorable market conditions. The regional bank grew its customer base by 33,210 clients, increased credit production by 21.7%, and expanded savings by 4.3% to €41.1B. Operating expenses remained controlled with only 1.2% growth despite inflationary pressures.

Navatar announced a new Claude-native deal engine that integrates Navatar CRM, Navatar AI, Salesforce Agentforce, and Claude to provide private equity and M&A firms with a governed, secure operating system for deal origination, relationship intelligence, and investment workflows. The platform combines structured operational AI with Claude's reasoning capabilities while maintaining data security and governance controls.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (CRMT) for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. The firm is preparing a class action lawsuit to recover investor losses.

Cathie Wood's Ark Investment Management holds $362 million in CRISPR Therapeutics across two ETFs. While known for gene-editing work like the FDA-approved Casgevy, the company is quietly developing CAR T-cell therapies that could address a market projected to exceed $60 billion annually by 2034. CRISPR's off-the-shelf CAR T approach using donor cells could reduce costs compared to patient-specific treatments, positioning it competitively despite being in early trial stages.

Caisse Régionale de Crédit Agricole Mutuel Alpes Provence executed buyback transactions of Cooperative Investment Certificates (CCI) from July 6-10, 2026, as authorized by the General Assembly on March 31, 2026. A total of 245 shares were repurchased across five trading days at prices ranging from €143.02 to €145.98 per share on the XPAR market through Kepler Cheuvreux.

A phase III randomized trial published in the New England Journal of Medicine found that two years of lenalidomide maintenance therapy provides equivalent overall survival to indefinite treatment for standard-risk multiple myeloma patients. The study of 516 patients showed 68.6% vs 69.0% survival rates at seven years, with indefinite treatment associated with higher toxicity and second primary cancer incidence. Results suggest fixed-duration maintenance could become the new standard of care.

Investor rights law firm Halper Sadeh LLC is investigating Element Solutions Inc, Crinetics Pharmaceuticals Inc, and Solstice Advanced Materials Inc for potential securities law violations and breaches of fiduciary duties related to their proposed mergers and acquisitions. The firm is examining whether insiders are receiving preferential benefits and whether transaction terms may limit competing offers.

Monteverde & Associates PC is investigating Cross Country Healthcare's proposed sale to KL Criss Cross Intermediate, LLC for $13.25 per share in cash. The firm is encouraging shareholders to act before the July 16, 2026 vote to determine if the deal is fair.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. (CRMT) for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. Investors who purchased CRMT securities may be eligible for compensation through a class action lawsuit.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be limiting superior competing offers.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholders' interests.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

Law firm Girard Sharp LLP is investigating potential securities claims on behalf of former Berry Global investors who received Amcor shares in the April 2025 merger. Amcor's stock price has declined significantly since the merger closed, prompting the investigation into possible securities violations.

LACROIX Group released its H1 2026 liquidity contract report showing 5,256 shares and €73,233.86 in cash as of June 30, 2026. The company reported Q1 2026 revenue of €122.8 million, up 5.9% year-over-year, with stabilization in Electronics activity and strong growth in the Environment segment. The group is implementing a €77 million investment program.

Amerant Investments announced the appointment of Ricardo Sucre as Head of International Wealth Management Business Development. Sucre brings over 20 years of experience from leading financial institutions including Morgan Stanley and Bolton Global Capital. The appointment reflects Amerant's strategic focus on expanding its international wealth management platform and attracting experienced financial advisors to its integrated banking and investment services model.

A class action lawsuit has been filed against Microsoft Corporation in the U.S. District Court for the Western District of Washington on behalf of investors who purchased Microsoft stock between May 1, 2025 and January 28, 2026. The lawsuit alleges that Microsoft made false or misleading statements regarding significant problems with its Copilot AI products, including brand positioning, user experience, and competitive positioning issues. The company allegedly failed to disclose that it needed to increase capital expenditures by billions of dollars and divert GPU/CPU capacity from Azure services to improve Copilot's competitiveness. Investors have until August 11, 2026 to apply to be appointed as lead plaintiff.

The article compares two biotech companies: CRISPR Therapeutics, which has achieved its first gene-editing product approval for sickle cell disease but faces significant losses and customer concentration risks, versus Viking Therapeutics, a clinical-stage company targeting the obesity and metabolic disorder markets with no approved products yet. While both are highly speculative, the author favors CRISPR due to its existing revenue and approved treatment, despite Viking's potentially larger market opportunity.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. The firm is preparing a class action lawsuit to recover investor losses.

Crédit Agricole has increased its ownership stake in Banco BPM to 29.3% through market purchases and derivative instruments, crossing the 25% threshold. The French bank views this as a long-term investment consistent with its strategy and highlights the strength of their industrial partnerships in consumer finance and insurance. The stake acquisition is expected to impact Crédit Agricole's CET 1 ratio by approximately -35 basis points.

Crédit Agricole S.A. announced two significant partnership developments: the acquisition of 100% of CAWL from Worldline, and a long-term partnership agreement with BCC-Grupo Cajamar. These moves represent the evolution of Crédit Agricole's strategic partnerships and expansion initiatives.

The CRISPR-based drug development platforms market is projected to grow at a CAGR of 11.4%, reaching USD 0.79 billion by 2031 from USD 0.46 billion in 2026. Growth is driven by advancements in precision medicine, gene therapy expansion, and increased biotech investments, though regulatory challenges and high development costs remain constraints.

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (CRMT), PennyMac Financial Services, Inc. (PFSI), and Putnam Investment Management LLC. The investigation into CRMT was triggered by the company's reported first-quarter loss of 69 cents per share compared to 15 cents in the prior year, causing the stock to plunge 18.2% on September 4, 2025. Investors who suffered losses are encouraged to join prospective class action lawsuits.

Santiago Urrutia made history by winning all three races at a single event in the 2026 Kumho FIA TCR World Tour driving the Geely Preface TCR at the Ricardo Tormo circuit in Valencia, Spain. This achievement demonstrates the performance, reliability, and engineering capabilities of Geely's racing program, with insights from motorsport directly improving the production Geely Preface sedan.

The Rosen Law Firm is investigating potential securities claims against America's Car-Mart, Inc. for allegedly issuing materially misleading business information. The company reported a first-quarter loss of 69 cents per share compared to 15 cents per share in the prior year, causing the stock to plunge 18.2% on September 4, 2025. The firm is preparing a class action lawsuit to recover investor losses.

Corvus Pharmaceuticals director David Scott Moore purchased 21,700 common shares for approximately $250,000 on June 11, 2026, marking his first investment in the company since joining as a director in October. Moore also received 15,000 stock options vesting in a year. The insider buy is viewed as a positive signal, though it should be considered alongside other investment factors.